Global Bioinformatics Market Outlook

Global Bioinformatics Market Outlook

The research reports ``Global Bioinformatics Market Outlook” provides an updated and detailed overview of the worldwide Bioinformatics industry. It examines the emerging trends of the market and provides exclusive forecasts, market revenue of different product categories, and snapshots of different players in the industry.

The global Bioinformatics industry has grown at a double-digit growth rate in the past and is expected to follow the same pattern in the next four years. US remains the largest market in the world, but Asia-Pacific countries, particularly India and China, are witnessing the fastest growth and are anticipated to emerge as the dominating forces in future.

The content database market, with revenues of over US$ 800 Million in 2006, represents the largest segment in the market; however, it is the analytical software segment that is posting the fastest growth rate.

Bioinformatics is full of opportunities. The sector is poised to open new avenues for the other related sectors also. But the biggest opportunity area in the Bioinformatics market will be in the drug discovery sector. Reduction of both the cost and time taken to discover a new drug due to fast development in the Bioinformatics tools and software zone is also making drug discovery an attractive field to venture in.

Key Findings

§ Genomics occupies the largest share out of the various Bioinformatics application areas, however, proteomics take the lead.
§ Phenomenal development in Information Technology (IT) and the Internet have fuelled the growth of the Bioinformatics industry.
§ By using computer-aided drug design, drug-designing companies can save over 30% in both the cost and time to discover a new drug.
§ Patent protection and lack of standardization remain the biggest challenge for the Bioinformatics industry.

Key Issues and Facts Analyzed

§ Evaluation of past, current and future market trends.
§ Discussion of the major segments in the Bioinformatics market.
§ An analysis of the major regions in the Bioinformatics market.
§ Future prospects of the Bioinformatics market.
§ Key application areas of the market.
§ Profile discussion of key players in this sector.

Key Players Analyzed

This section provides an overview and key financial information of prominent players of the Bioinformatics market like IBM Life Sciences, Accelrys, Affymetrix, Applied Biosystems Group, Compugen Ltd, Ciphergen Biosystems, CuraGen Corporation, Celera Genomics Group, , Incyte Corporation and Tripos Inc.

Research Methodology Used

Information Sources
The information provided in the report has been sourced credible sources like books, newspapers, trade journals, and white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to more than 3000 paid databases.

Analysis Methods
The analysis methods includes ratio analysis, historical trend analysis, linear regression analysis using software tools, judgmental forecasting, and cause and effect analysis.

For the purpose of this report, the following segments have been considered as a part of the Bioinformatics market:

Analysis software and services, Content market and IT Infrastructure and services market

The following currency conversion has been taken in the report:
1 US$ = INR 40.81, AUS$ 1.18, €0.74, RMB 8.27

1. Analyst View

2. Emergence of Bioinformatics
2.1 Growth in Information Technology & Internet
2.2 Rising Costs & Timelines in Drug Delivery
2.3 Dwindling Drug Pipelines & Patent Expirations
2.4 Efficient Storage & Analysis of Research Data

3. Global Bioinformatics Market
3.1 Current & Future Scenario
3.2 By Region
3.2.1 US
3.2.2 Europe
3.2.3 Asia-Pacific
3.2.3.1 Japan
3.2.3.2 India
3.2.3.3 China
3.2.3.4 South Korea
3.2.3.5 Taiwan
3.2.3.6 Singapore
3.2.3.7 Australia
3.3 By Segment
3.3.1 Analysis Software & Services Market
3.3.2 Content Market
3.3.3 IT Infrastructure & Other Services Market
3.4 By Application
3.4.1 Genomics
3.4.2 Proteomics
3.4.3 Pharmacogenomics
3.4.4 Drug Discovery & Cheminformatics

4. Industry Analysis
4.1 Opportunities
4.1.1 Pharmaceutical & Biopharmaceutical Industry
4.1.2 Agri-biotechnology & Industrial Biotechnology Industry
4.1.3 Bioinformatics Outsourcing
4.1.4 Drug Delivery Market
4.2 Challenges
4.2.1 Lack of Standardization
4.2.2 Patent-related Issues
4.2.3 Limited User Base

5. Key Players
5.1 Accelrys, Inc.
5.2 Affymetrix, Inc.
5.3 Applied Biosystems Group
5.4 Celera Genomics Group
5.5 Ciphergen Biosystems
5.6 Compugen Ltd.
5.7 CuraGen Corporation
5.8 Gene Logic Inc.
5.9 IBM Life Sciences
5.10 Incyte Corporation
5.11 Tripos, Inc.

List of Figures:
Figure 2-1: Reduction in Time & Cost (%) by Using Computer Aided Drug Design Method
Figure 2-2: Worldwide - Forecast for Number of Drugs Facing Patent Expirations* (2007-2011)
Figure 2-3: Worldwide - Forecast for Loss due to Drug Patent Expirations* (in Billion US$), 2007-2011
Figure 3-1: Worldwide - Bioinformatics Market (in Million US$), 2002-2006E
Figure 3-2: Worldwide - Forecast for Bioinformatics Market (in Million US$), 2007-2010
Figure 3-3: US - Share in Global Bioinformatics Market (%), 2007F
Figure 3-4: Europe - Bioinformatics Market (in Million US$), 2004 & 2006
Figure 3-5: Europe - Percentage of R&D Spending & Drugs in Pipeline by Company Size, 2004
Figure 3-6: Europe - Forecast for Bioinformatics Market (in Million US$), 2007-2013
Figure 3-7: Japan - Bioinformatics Market (in Billion Yen), 2001-2003
Figure 3-8: India - Bioinformatics Market (in Rs Crore), 2002-03 to 2006-07
Figure 3-9: India - Share of Exports & Domestic Use in Bioinformatics Market (%), 2006-07
Figure 3-10: South Korea - Bioinformatics Market, Exports & Imports (in ‘000 US$), 2004
Figure 3-11: Taiwan - Bioinformatics Market (in Million US$), 2001-2003E & 2006E
Figure 3-12: Taiwan - Bioinformatics Market Imports (in Million US$), 2001-2003E & 2006E
Figure 3-13: Australia - Biotech Companies by Sector (%), 2006
Figure 3-14: Worldwide - Bioinformatics Market by Product (%), 2006E
Figure 3-15: Worldwide - Forecast for Bioinformatics Market by Product (%), 2010
Figure 3-16: Worldwide - Analysis Software & Services Market (in Million US$), 2005 & 2006E
Figure 3-17: Worldwide - Forecast for Analysis Software & Services Market (in Million US$), 2007 –2010
Figure 3-18: Worldwide - Analysis Software & Services Market by Application (%), 2006E
Figure 3-19: Worldwide - Forecast for Analysis Software & Services Market by Application (%), 2009
Figure 3-20: Worldwide - Content Market (in Million US$), 2005 & 2006E
Figure 3-21: Worldwide - Forecast for Content Market (in Million US$), 2007-2010
Figure 3-22: Worldwide - IT Infrastructure & Other Services Market (in Million US$), 2005 & 2006E
Figure 3-23: Worldwide - Forecast for IT Infrastructure & Other Services Market (in Million US$), 2007-2010
Figure 3-24: Worldwide - Bioinformatics Market by Application (%), 2001
Figure 3-25: Worldwide - Genomics Market (in Billion US$) 2002 & 2006E
Figure 3-26: Worldwide - Forecast for Genomics Market (in Billion US$), 2007-2009
Figure 3-27: Worldwide - DNA Sequencing & Proteomics Market (in Billion US$), 2004-2006E
Figure 3-28: Worldwide - Forecast for DNA Sequencing & Proteomics Market (in Billion US$), 2007-2009
Figure 3-29: Worldwide - Application of Proteomics in Bioinformatics Market (in Million US$), 2005-2007
Figure 3-30: Worldwide - Pharmacogenomics Market by Core Segment (in Million US$), 2004-2006E
Figure 3-31: Worldwide - Forecast for Pharmacogenomics Market by Core Segment (in Million US$), 2007-2009
Figure 3-32: Worldwide - Pharmacogenomics Market (in Million US$), 2004-2006E
Figure 3-33: Worldwide - Forecast for Pharmacogenomics Market (in Million US$), 2007-2009
Figure 3-34: Worldwide - Application of Pharmacogenomics in Bioinformatics Market (in Million US$), 2005-2007
Figure 3-35: Worldwide - Drug Discovery Expenditure (in Billion US$), 2002 & 2006E
Figure 4-1: Worldwide - Drug Delivery Market (in Billion US$), 2005 & 2006E
Figure 4-2: Worldwide - Forecast for Drug Delivery Market (in Billion US$), 2007–2010

List of Tables:
Table 3-1: Growth in Key Bioinformatics Databases (December 2004 & December 2005)
Table 5-1: Accelrys, Inc. - Key Financials (in Million US$), 2005-2007
Table 5-2: Affymetrix, Inc. - Key Financials (in Million US$), 2004-2006
Table 5-3: Applied Biosystems Group - Key Financials (in Million US$), 2004-2006
Table 5-4: Celera Genomics Group - Key Financials (in Million US$), 2004-2006
Table 5-5: Ciphergen Biosystems - Key Financials (in Millions US$), 2004-2006
Table 5-6: Compugen Ltd. - Key Financials (in Million US$), 2004-2006
Table 5-7: CuraGen Corporation - Key Financials (in Million US$), 2004-2006
Table 5-8: Gene Logic Inc. - Key Financials (in Million US$), 2004-2006
Table 5-9: Incyte Corporation - Key Financials (in Million US$), 2004-2006
Table 5-10: Tripos, Inc. - Key Financials (in Million US$), 2004-2006